<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi> receptor β (ERβ) is expressed in immune cells and studies have suggested an antiproliferative function of ERβ </plain></SENT>
<SENT sid="1" pm="."><plain>We detected ERβ expression in murine T- and human B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines and analyzed the effects of <z:chebi fb="1" ids="23965">estradiol</z:chebi> and selective ERβ <z:chebi fb="4" ids="48705">agonists</z:chebi> on <z:hpo ids='HP_0002665'>lymphoma</z:hpo> growth in culture and in vivo </plain></SENT>
<SENT sid="2" pm="."><plain>Treating the cells with <z:chebi fb="1" ids="23965">estradiol</z:chebi> had minor effects on cell growth, whereas the selective ERβ <z:chebi fb="4" ids="48705">agonists</z:chebi> diarylpropionitrile (DPN) and KB9520 showed a strong antiproliferative effect </plain></SENT>
<SENT sid="3" pm="."><plain>When grafting mice with murine T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, male mice developed larger <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> compared with female mice, a difference that was abolished following ovariectomy, showing <z:chebi fb="0" ids="50114">estrogen</z:chebi>-dependent growth in vivo </plain></SENT>
<SENT sid="4" pm="."><plain>To investigate whether <z:hpo ids='HP_0002665'>lymphoma</z:hpo> growth may be inhibited in vivo by ERβ <z:chebi fb="4" ids="48705">agonist</z:chebi> treatment, mice grafted with murine <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells were treated with DPN or KB9520 </plain></SENT>
<SENT sid="5" pm="."><plain>Both ERβ-selective <z:chebi fb="4" ids="48705">agonists</z:chebi> strongly inhibited <z:hpo ids='HP_0002665'>lymphoma</z:hpo> growth </plain></SENT>
<SENT sid="6" pm="."><plain>The reduced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size seen following either DPN or KB9520 treatment was due to reduced proliferation and <z:mp ids='MP_0006042'>increased apoptosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Our results show an ERβ ligand-dependent antiproliferative effect of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells expressing endogenous ERβ and that <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell growth in vivo can efficiently be inhibited by ERβ <z:chebi fb="4" ids="48705">agonists</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>This suggests that ERβ <z:chebi fb="4" ids="48705">agonists</z:chebi> may be useful in the treatment of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>